BioCentury
ARTICLE | Management Tracks

AZ’s Marshall becomes CEO of Juvenescence

Plus: Gomez retires as CEO from Siga, and updates from Full-Life, Remix, Sanotize and more

January 18, 2023 1:25 AM UTC

Longevity company Juvenescence Ltd. named Richard Marshall as new CEO, succeeding Gregory Bailey, who will remain as executive chairman. Marshall was SVP, global development head, respiratory and immunology at AstraZeneca plc (LSE:AZN; NASDAQ:AZN), and held roles of increasing responsibility at GSK plc (LSE:GSK; NYSE:GSK) over 16 years. 

Phil Gomez will retire as CEO of Siga Technologies Inc. (NASDAQ:SIGA) this year. The company has initiated a search for a new CEO. SIGA is developing smallpox and monkeypox therapies. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article